AUC, sensitivity, specificity, LR+, and LR‐, as well as, optimal cut‐off for serum biomarkers (ALT, AST, AFP, and NLR) for diagnosing HBV‐HCC are shown in Table 3. This evidence concerns the gene AFP and hepatocellular carcinoma.